2016-03-11T00:00:00.000-05:00
Life Sciences George,0.54679
past decade,0.711908
previously isolated model,-0.452623
multiple sclerosis,-0.648427
Big Pharma campuses,0.54679
weekly EuroBiotech Report,0.784398
George Freeman,0.54679
biopharma deals,0.269587
biotech hubs,0.42779
newfound willingness,0.711908
previous resistance,-0.229504
radionuclide therapies,0.376031
clinical development,0.376031
transatlantic biotech,-0.471463
acromegaly drug,-0.4503
latest edition,0.784398
big prize,-0.351467
influential biotechnology news,0.603129
portfolio firm Aprea,-0.229504
cash reserves,-0.471463
Phase III trial,-0.459662
pemphigus vulgaris,-0.351467
Largest Swedish fundraising,0.445583
rare disease program,-0.471463
drug development industry,0.256961
ex-Big Pharma campuses,0.4112
free daily email,0.760667
Pharma campuses,0.478995
email | Twitter,0.215999
Novartis,-0.345668
financial constraints,-0.229504
Karolinska Development,-0.452623
pipeline prioritization,-0.471463
autoimmune indications,-0.33987
